Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-12-23

FDA Approved: SAXENDA — Original Application (Novo Nordisk)

View source ↗

Summary

FDA approved Saxenda (liraglutide) for the original indication of chronic weight management in adults. This approval established liraglutide as a pharmacologic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SAXENDA (liraglutide)

Snippet

ORIG AP for SAXENDA (LIRAGLUTIDE)